- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/44 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
Patent holdings for IPC class C07C 235/44
Total number of patents in this class: 16
10-year publication summary
|
0
|
1
|
2
|
0
|
1
|
2
|
3
|
0
|
0
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Life Technologies Corporation | 3463 |
3 |
| Genzyme Corporation | 1383 |
2 |
| Bristol-myers Squibb Company | 4747 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| The Trustees of Columbia University in the City of New York | 3663 |
1 |
| Fab Pharma S.A.S. | 5 |
1 |
| Konkuk University Industrial Cooperation Corp. | 337 |
1 |
| San Jose State University Research Foundation | 34 |
1 |
| Schrodinger, Inc. | 55 |
1 |
| The Trustees of Princeton University | 1277 |
1 |
| University of Surrey | 220 |
1 |
| Republic of Korea(management : Rural Development Administration) | 107 |
1 |
| Appia Pharmaceuticals LLC | 1 |
1 |
| Other owners | 0 |